Researchers at Brigham and Women’s Hospital have developed a nasal spray that could provide broad-spectrum protection against ...
The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.